Company / Operating Margin
Arcadia Biosciences, Inc. Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-72.3%
FY2025
5-year range
-524.0% / -72.3%
FY2021-FY2025
Trend
+47.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has increased for 3 consecutive years, from -524.0% in FY2022 to -72.3% in FY2025.
Based on SEC 10-K filings.
-72.3% in FY2025 with a 5-year CAGR of +1585.6%.
Improved from -188.8% to -72.3% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +451.7pp
- 5-Year Change
- +1585.6pp
- 10-Year Change
- -
Key checks
Key Insights
- Arcadia Biosciences, Inc.'s operating margin has grown for 3 consecutive years.
- In FY2025, operating margin increased 47.2% year-over-year.
- Lowest operating margin in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 7.60 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -72.3% | +47.2% |
| FY2024 | -137.0% | +27.4% |
| FY2023 | -188.8% | +64.0% |
| FY2022 | -524.0% | -229.4% |
| FY2021 | -159.1% | +90.4% |
| FY2020 | -1657.9% | -43.9% |
| FY2019 | -1152.3% | -224.1% |
| FY2018 | -355.6% | +39.1% |
| FY2017 | -584.1% | -103.2% |
| FY2016 | -287.5% | -32.5% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026